Form 4: Medtronic Director Scott C. Donnelly Reports Stock Transactions

Director Scott C. Donnelly reports acquisition and disposal of Medtronic plc ordinary shares.

Summary

• On April 28, 2025, Scott C. Donnelly, a director of Medtronic plc, acquired 2,083 ordinary shares at a price of $84.04.
• These shares were obtained through an award of restricted stock units that vest on the one-year anniversary of the award date.
• Additionally, Mr. Donnelly disposed of 216 ordinary shares on April 29, 2025, at a price of $84.60 for payment of taxes upon the vesting of restricted stock units.
• Following these transactions, Mr. Donnelly beneficially owns 21,630 ordinary shares.
• The report also includes 159 shares acquired through dividend reinvestment since the last report.

Sentiment

Score: 6

Explanation: Neutral sentiment as the document primarily reports routine stock transactions by a company director. The acquisition of shares is a mildly positive signal, while the disposal for tax purposes is neutral.

Positives

• The acquisition of shares through restricted stock units indicates confidence in the company's future performance.

Negatives

• The disposal of shares to cover taxes could be seen as a minor negative, although it's a common practice.

Risks

• There are no specific risks highlighted in this document, as it primarily reports stock transactions.

Industry Context

This filing is a routine disclosure required by the SEC for corporate insiders, providing transparency to the market regarding their transactions in the company's stock.

Comparison to Industry Standards

• Form 4 filings are standard practice for directors and officers of publicly traded companies like Medtronic, similar to filings made by insiders at companies like Johnson & Johnson, Abbott Laboratories, and Boston Scientific.
• The transactions reported are typical for executives receiving stock-based compensation and managing their tax obligations.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders, as they are routine and do not significantly alter the ownership structure of the company.

Key Dates

Keywords

Medtronic, Scott C. Donnelly, Director, Ordinary Shares, Stock Transactions, Form 4, Restricted Stock Units, Dividend Reinvestment